Overview
Neuralstem develops neural stem cell-based therapies and small-molecule compounds targeting neurological conditions including ALS and spinal cord injury.
More in Neuropharmaceuticals
Latest industry news
China Accelerates Its Brain-Computer Interface Ambitions in a Major National Push
2026-09-05 · Industry
Tether Evo Tackles Brain-Computer Interface's Most Stubborn Engineering Problem
2026-09-04 · Research
FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD
2026-09-03 · Policy
Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%
2026-09-02 · Industry
Company details
Category
💊 Neuropharmaceuticals
Location
Germantown, MD, USA
Funding
Publicly traded (NASDAQ: CUR)
Website
www.neuralstem.comListed
2026-07-06
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →